BioSpace News Archive

BioMidwest

Fresenius Kabi Issues Voluntary Nationwide Recall of Midazolam Injection, USP, 2 mg/2 mL Due to Reports of Blister Packages Containing Syringes of Ondansetron Injection, USP, 4 mg/2 mL

The product mislabeled as Midazolam Injection, USP, 2 mg/2 mL contains syringes containing and labeled as Ondansetron Injection, USP, 4 mg/2 mL.

November 3, 2017

·

3 min read

Exercise of Employee Share Options and Restricted Stock Units in Targovax ASA

Following the end of the exercise window, no options or RSUs have been exercised or settled and thus there will not be any changes in the share capital of the Company relating to this exercise window.

November 3, 2017

·

2 min read

Business

Digirad Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2017

Total revenues for the third quarter were $28.6 million, compared to $31.1 million in the third quarter of the prior year.

November 3, 2017

·

18 min read

Genetown

SeqLL Installs true Single Molecule Sequencing (tSMS) Instrument to Support Oncology Research by Dr. David Ting, MD at the Harvard-MGH Cancer Center

Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist with a focus on gastrointestinal malignancies.

November 3, 2017

·

3 min read

Ablynx: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The “Transparency Law”) – Nov. 3, 2017

In a first notification (dated 31 October 2017), Millennium Group Management LLC notified Ablynx that it holds 1,889,639 voting securities of Ablynx.

November 3, 2017

·

4 min read

BioMidwest

Vertex Announces Presentations of Data at North American Cystic Fibrosis Conference that Demonstrate Important Progress Toward Goal of Helping All People With CF

Vertex announced presentations of data at the Annual North American Cystic Fibrosis Conference (NACFC), November 2 to 4, 2017, in Indianapolis, from across the company’s portfolio of cystic fibrosis (CF).

November 3, 2017

·

20 min read

Business

Ascendis Pharma Announces Third Quarter 2017 Financial Results Conference Call on November 16

The company will review its third quarter 2017 financial results and provide a business update.

November 3, 2017

·

3 min read

Drug Development

Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase III Study of Auryxia (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-Dialysis Dependent Chronic Kidney Disease

The presentations are based on post-hoc analysis of the Phase 3 study of ferric citrate in adults with iron deficiency anemia and non-dialysis dependent chronic kidney disease.

November 3, 2017

·

11 min read

Business

Dova Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 9, 2017

A question-and-answer session will follow Dova’s remarks.

November 3, 2017

·

1 min read

Business

Pacific Biosciences Appoints Kathy Ordonez as Chief Commercial Officer

Ms. Ordonez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and RainDance Technologies.

November 3, 2017

·

3 min read